Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT05211726
Other study ID # 1760500
Secondary ID P20GM113125
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date January 4, 2022
Est. completion date September 1, 2024

Study information

Verified date March 2024
Source University of Delaware
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will focus on improving brain health through dietary modification of added sugars in middle aged adults (50- 64 years old). Participants will be fed two 10-day diets (one diet containing 5% of total energy from added sugars and one diet containing 25% of total energy from added sugars) and examine blood vessel function, hippocampus structure using a MRI, and memory performance.


Description:

Aging is the primary risk factor for Alzheimer's disease (AD) which is the most common form of dementia and among the fastest growing causes of morbidity and mortality in the United States. The risk factors for AD emerge during midlife and are similar to cardiovascular and cerebrovascular diseases. The impact of midlife peripheral vascular changes on cardiovascular risk are worsened by poor lifestyle habits, including eating a diet that contains a lot of added sugars (defined as all caloric sweeteners added to food during processing or preparation). One effect of eating a high added sugar diet is an elevation in blood triglycerides (TGs), which impairs blood vessel function by causing inflammation; however, it is not known whether eating a lot of added sugars affects the blood vessels in the brain. The purpose of this project is to determine if there is a link between added sugar intake and brain health in midlife adults. Our hypothesis is that eating excess added sugar impairs the structure and function of an area of the brain called the hippocampus by increasing plasma TGs and systemic inflammation. To test this, we will have people eat a high and low sugar diet for 10 days each (in a random order) and test how each diet affects their blood vessel function, the structure of their hippocampus, and their memory performance. We expect to show that eating a diet that contains a lot of added sugars worsens brain health compared to a diet that contains few added sugars. The data generated from this project will help us better understand risk factors for dementia and will be used to support a future grant proposal to the National Institutes of Health aimed at lowering added sugar intake in mid-life adults and individuals with mild cognitive impairment.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 40
Est. completion date September 1, 2024
Est. primary completion date May 1, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 50 Years to 64 Years
Eligibility Inclusion Criteria: - ability to provide informed consent; - men and postmenopausal women aged 50-64 years; - habitual intake of added sugars =15% of total calories; - systolic BP < 130 mmHg; diastolic BP < 90 mmHg; - body mass index (BMI) <30 kg/m2 and % body fat < 25% for men and < 33% for women; - fasting triglycerides < 200 mg/dl (< 2.3 mmol/L); - LDL cholesterol <160 mg/dl (4.14 mmol/L); - fasting plasma glucose <126 mg/dl (<7.0 mmol/L) and hemoglobin A1C < 6.5% at screening; - weight stable in the prior 6 months (= 2 kg weight change); - blood chemistries indicative of normal liver enzymes and renal function (estimated glomerular filtration rate using the MDRD prediction equation must be >60 ml/min/1.73 m^2). Exclusion Criteria: - current use of medications or supplements known to lower blood triglycerides or cholesterol (e.g., fibrates, statins, high dose niacin, high dose omega-3 supplement); - chronic clinical diseases (e.g., coronary artery/peripheral artery/cerebrovascular diseases, heart failure, diabetes, chronic kidney disease requiring dialysis, neurological or autoimmune conditions affecting cognition (e.g. Alzheimer's disease or other form of dementia, Parkinson's disease, epilepsy, multiple sclerosis, large vessel infarct); - major psychiatric disorder (e.g. schizophrenia, bipolar disorder); - major depressive disorder (PHQ-9 = 10); - current or past (i.e., last 3 months) use of anti-hypertensive or other cardiovascular-acting medications known to influence vascular function and/or arterial stiffness; - current medication use likely to affect CNS functions (e.g. long active benzodiazepines); - concussion within last 2 years and = 3 lifetime concussions; - heavy alcohol consumption (defined by the CDC and USDA as =8 drinks/week for women and =15 drinks/week for men). - claustrophobia, metal implants, pacemaker or other factors affecting feasibility and/or safety of MRI scanning; - recent major change in health status within previous 6 months (i.e., surgery, significant infection or illness); - current smoking within the past 3 months; - High degree of physical activity as defined by = 25 leisure MET-hours/week, within the past 3 months.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Low Added Sugar Diet
Consumption of 10 days of a diet low in added sugars (5% of total caloric intake)
High Added Sugar Diet
Consumption of 10 days of a diet high in added sugars (25% of total caloric intake)

Locations

Country Name City State
United States University of Delaware Newark Delaware

Sponsors (2)

Lead Sponsor Collaborator
University of Delaware National Institute of General Medical Sciences (NIGMS)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change from baseline in systolic blood pressure at the end of each diet 24-hour ambulatory blood pressure Over 1.5 months. Once at baseline and again at the end of each 10 day diet (low and high added sugar), separated by a 2 week washout period
Primary Change from baseline in arterial compliance at the end of each diet Carotid artery compliance will be calculated as the change in cross sectional area of the carotid artery for a given change in carotid pressure using transcutaneous tonometry coupled with duplex ultrasound Over 1.5 months. Once at baseline and again at the end of each 10 day diet (low and high added sugar), separated by a 2 week washout period
Primary Change from baseline in cerebrovascular reactivity at the end of each diet Total cerebral perfusion measured using pseudo-continuous arterial spin labeling in response to 3-minutes of hypercapnia (+9 mmHg increase in PETCO2) Over 1.5 months. Once at baseline and again at the end of each 10 day diet (low and high added sugar), separated by a 2 week washout period
Primary Change from baseline in hippocampal stiffness at the end of each diet Magnetic Resonance Imaging (MRI) of the brain to collect structural T1- and T2-weighted images Over 1.5 months. Once at baseline and again at the end of each 10 day diet (low and high added sugar), separated by a 2 week washout period
Primary Change from baseline in hippocampal damping ratio at the end of each diet Magnetic Resonance Elastography (MRE) of the brain to collect microstructural integrity while the head will be vibrated using the resoundant acoustic driver system Over 1.5 months. Once at baseline and again at the end of each 10 day diet (low and high added sugar), separated by a 2 week washout period
Primary Change from baseline in delayed recall memory (e.g.words) at the end of each diet Administration of the Hopkins Verbal Learning Test (HVLT-R) Over 1.5 months. Once at baseline and again at the end of each 10 day diet (low and high added sugar), separated by a 2 week washout period
Primary Change from baseline in delayed recall memory (e.g. pictures) at the end of each diet Administration of the Brief Visuospatial Memory Test (BVMT-R) Over 1.5 months. Once at baseline and again at the end of each 10 day diet (low and high added sugar), separated by a 2 week washout period
Secondary Change from baseline in pulse wave velocity at the end of each diet Pulse wave velocity measured using transcutaneous tonometry Over 1.5 months. Once at baseline and again at the end of each 10 day diet (low and high added sugar), separated by a 2 week washout period
Secondary Change from baseline in cognitive domain (e.g. processing speed) at the end of each diet Administration of the NIH Toolbox Pattern Comparison test Over 1.5 months. Once at baseline and again at the end of each 10 day diet (low and high added sugar), separated by a 2 week washout period
Secondary Change from baseline in cognitive domain (e.g. inhibition) at the end of each diet Administration of the NIH Toolbox Flanker test Over 1.5 months. Once at baseline and again at the end of each 10 day diet (low and high added sugar), separated by a 2 week washout period
Secondary Change from baseline in lipid profile at the end of each diet Blood biomarkers of lipid profile (e.g. cholesterol, triglycerides, HDL, LDL, and VLDL) Over 1.5 months. Once at baseline and again at the end of each 10 day diet (low and high added sugar), separated by a 2 week washout period
Secondary Change from baseline in inflammation at the end of each diet Blood biomarkers of inflammation (e.g. cytokines and interleukins) Over 1.5 months. Once at baseline and again at the end of each 10 day diet (low and high added sugar), separated by a 2 week washout period
Secondary Change from baseline in oxidative stress at the end of each diet Blood biomarkers of oxidative stress (e.g. superoxide) Over 1.5 months. Once at baseline and again at the end of each 10 day diet (low and high added sugar), separated by a 2 week washout period
Secondary Change from baseline in sleep quality compared to each diet Sleep quality will be continuously measured for 10 days using an Actiwatch. Over 1.5 months. Once at baseline and again at the end of each 10 day diet (low and high added sugar), separated by a 2 week washout period
See also
  Status Clinical Trial Phase
Completed NCT05433233 - Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension N/A
Recruiting NCT06032065 - SMART Exercise for PAD Phase 3
Active, not recruiting NCT05293730 - Trial of the Impact of the Electronic Frailty Integrated With Social Needs N/A
Recruiting NCT03932162 - Gene Expression Changes In Young and Geriatric Skin Early Phase 1
Completed NCT04064528 - Effects of Age on Amino Acid Delivery to Tendon N/A
Active, not recruiting NCT03366129 - Blood-Brain Barrier Disruption in People With White Matter Hyperintensities Who Have Had a Stroke
Completed NCT06029920 - Influence of Overground Walking on Biomarkers, Cognitive Function, and Quality of Life in Elderly With Mild Cognitive Impairment N/A
Recruiting NCT05566938 - Study to Design a Precision Nutrition Strategy at a Group Level in the Elderly N/A
Recruiting NCT05543980 - Leg Heat Therapy in Elderly Individuals Phase 2
Completed NCT04894929 - Comprehensive Geriatric Assessment in the Monitoring of Functional Improvement N/A
Not yet recruiting NCT06071130 - Emotion, Aging, and Decision Making N/A
Enrolling by invitation NCT04641663 - Multi-target Dietary Supplement Tolerability in an Aging Population (MTDSST) N/A
Completed NCT04088006 - The Evaluation of Efficacy and Safety of Hyaluronic Acid Injection on Skin Moisturization and Elasticity N/A
Completed NCT03695081 - Patient Pathway Pharmacist - Optimal Drug-related Care N/A
Recruiting NCT05424263 - Acetate and Age-associated Arterial Dysfunction Phase 2
Completed NCT05601713 - Mitigating Heat-induced Physiological Strain and Discomfort in Older Adults Via Lower Limb Immersion and Neck Cooling N/A
Completed NCT04551339 - Zinc Versus Multivitamin Micronutrient Supplementation in the Setting of COVID-19 N/A
Recruiting NCT04997577 - Speech Perception and High Cognitive Demand N/A
Completed NCT05922475 - Efficacy of Pre-sleep or Post-exercise Protein During 12 Weeks of Resistance Exercise Training N/A
Completed NCT04015479 - Peanut Protein Supplementation to Augment Muscle Growth and Improve Markers of Muscle Quality and Health in Older Adults N/A